Sale!

Immunophenotyping by Flow Cytometry Leukemia Monitoring Panel Hairy Cell Test

Original price was: $450.Current price is: $326.

-28%

The Immunophenotyping by Flow Cytometry Leukemia Monitoring Panel Hairy Cell Test is a specialized diagnostic tool designed for comprehensive monitoring and management of Hairy Cell Leukemia. This advanced flow cytometry test analyzes specific cell surface markers to detect abnormal B-cell populations characteristic of HCL. It provides crucial information about disease progression, treatment response, and minimal residual disease detection. The test is essential for patients undergoing treatment for Hairy Cell Leukemia, helping oncologists and hematologists make informed decisions about therapy adjustments. With a turnaround time of same-day reporting and samples processed daily by 9 AM, this test offers timely results for critical treatment decisions. The discounted price is $326 USD, making advanced leukemia monitoring accessible to patients across the United States.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Immunophenotyping by Flow Cytometry Leukemia Monitoring Panel Hairy Cell Test

Comprehensive Hairy Cell Leukemia Monitoring and Analysis

The Immunophenotyping by Flow Cytometry Leukemia Monitoring Panel Hairy Cell Test represents a cutting-edge diagnostic approach specifically designed for the comprehensive evaluation and monitoring of Hairy Cell Leukemia (HCL). This sophisticated laboratory analysis utilizes advanced flow cytometry technology to characterize and quantify specific cell surface markers on abnormal B-lymphocytes, providing hematologists and oncologists with critical insights into disease status, treatment response, and potential relapse detection.

What This Advanced Test Measures and Detects

This specialized immunophenotyping panel targets specific antigen expression patterns that are characteristic of Hairy Cell Leukemia:

  • CD19, CD20, CD22, and CD79a – B-cell lineage markers
  • CD11c, CD25, CD103 – Characteristic HCL markers
  • CD5, CD10, CD23 – Exclusion markers for differential diagnosis
  • Surface immunoglobulin light chain restriction analysis
  • Minimal residual disease detection capabilities

The test provides quantitative assessment of abnormal cell populations, enabling precise monitoring of treatment response and early detection of disease recurrence.

Who Should Consider This Essential Test

This comprehensive monitoring panel is recommended for individuals experiencing symptoms or clinical scenarios including:

  • Patients with confirmed Hairy Cell Leukemia undergoing treatment
  • Individuals presenting with unexplained fatigue, weakness, or pallor
  • Patients with recurrent infections or unexplained fevers
  • Individuals demonstrating abnormal bruising or bleeding tendencies
  • Patients with unexplained weight loss or night sweats
  • Those with palpable spleen enlargement or abdominal discomfort
  • Individuals with abnormal complete blood count results
  • Patients requiring post-treatment monitoring for minimal residual disease

Significant Benefits of Advanced Leukemia Monitoring

Choosing this comprehensive immunophenotyping test provides numerous clinical advantages:

  • Early Detection Capability: Identifies minimal residual disease before clinical symptoms appear
  • Treatment Guidance: Provides objective data for treatment modification decisions
  • Prognostic Information: Offers insights into disease progression and treatment response
  • Rapid Turnaround: Same-day reporting ensures timely clinical decisions
  • Comprehensive Analysis: Multiple marker assessment provides complete disease characterization
  • Expert Interpretation: Results analyzed by specialized hematopathologists

Understanding Your Test Results

Your immunophenotyping results will provide detailed information about:

  • Disease Burden: Percentage of abnormal HCL cells in the sample
  • Marker Expression: Specific antigen patterns characteristic of HCL
  • Treatment Response: Comparison with previous results to assess therapy effectiveness
  • Residual Disease: Detection of minimal numbers of persistent abnormal cells
  • Differential Diagnosis: Confirmation of HCL versus other B-cell malignancies

Your hematologist or oncologist will interpret these results in the context of your clinical presentation and treatment history to guide your ongoing care.

Test Pricing and Availability

Test Name Regular Price Discount Price
Immunophenotyping by Flow Cytometry Leukemia Monitoring Panel Hairy Cell Test $450 USD $326 USD

Nationwide Accessibility and Convenient Testing

We maintain comprehensive testing facilities across major metropolitan areas throughout the United States, including:

  • New York City and surrounding tri-state area
  • Los Angeles and Southern California region
  • Chicago and Midwest locations
  • Houston, Dallas, and Texas facilities
  • Miami, Orlando, and Florida centers
  • Atlanta and Southeastern locations
  • Seattle, Portland, and Pacific Northwest sites

Our state-of-the-art laboratories process samples daily by 9 AM with same-day reporting, ensuring you receive timely results for critical treatment decisions.

Take Control of Your Leukemia Management Today

Don’t wait to get the comprehensive monitoring your condition requires. Our specialized immunophenotyping test provides the detailed information needed for optimal Hairy Cell Leukemia management. With our discounted pricing and nationwide availability, advanced leukemia monitoring has never been more accessible.

Call us today at +1(267) 388-9828 to schedule your test or speak with our hematology specialists about your monitoring needs. Early detection and precise monitoring can make all the difference in your treatment journey.